Oscar Health price target raised to $39 from $35 at Barclays
Upside potential from analyst target upgrade.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Upside potential from analyst target upgrade.
What happened, with direct paths to the underlying reporting
Barclays raises Oscar Health price target to $39; current price is $26.75.
Target: $39
Posted price: $26.75
Analyst firm: Barclays
Analyst: Andrew Mok
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.